RT @radiolobt: Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer…
RT @radiolobt: Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer…
PSMA No será la panacea. Su utilidad tras ADT prolongada ya está cuestionada. https://t.co/IfhtsvpUnI
That makes sense but contradicts another report but maybe this one is a PSMA flare phenomenon "Conclusion: Inhibition of AR can increase PSMA expression in prostate cancer metastases and increase the number of lesions visualized using PSMA PET." DOI: 10.
RT @radiolobt: Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer…
RT @radiolobt: Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer…
RT @radiolobt: Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer…
RT @radiolobt: Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer…
Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer https://t.co/yjdY8TIsOA #prostatecancer #psma https://t.co/BQX7rNY8x1
Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer. https://t.co/5tkI1tVbMX